Seino Y, Min KW, Niemoeller E, Takami A
Formally known as GLP-1 agonists, GLP-1s are a class of medication primarily used to manage Type 2 diabetes
People who may be at higher risk include: People experiencing rapid or significant weight loss Those taking higher-dose GLP-1 medicines, particularly semaglutide or tirzepatide Women, who reported hair loss more often in current studies People with low protein intake or deficiencies in iron, zinc, vitamin D, and B vitamins Individuals with existing nutritional deficiencies or other conditions that affect hair growth What to Expect if Hair Loss Occurs After Starting GLP-1 Drugs Can Hair Loss Be Prevented While Taking GLP-1 Drugs
For instance, GLP-1 agonists like Wegovy are often prescribed for those with type 2 diabetes
When unavailable, tirzepatide + Tesamorelin offers a reasonable alternative with established safety profiles for both compounds